Robert Yates will become president of the Merck Millipore division of Merck KGaA on 1 September. He will report to Bernd Reckmann, a member of Merck’s executive board who is responsible for the Chemicals business sector, which includes the Merck Millipore and Performance Materials divisions. Reckmann has led the division since Merck’s acquisition of the Millipore Corporation in July last year.
Reckmann said that now Millipore has been integrated into Merck the group is entering the next phase of its growth plan, which will involve penetrating further into new and established markets and optimising the firm’s infrastructure.
‘To fully focus on these activities we decided to appoint a dedicated president of the Merck Millipore division,’ he said.
Yates joins Merck Millipore from the diagnostics division of Roche, where he led the Life Sciences business in Penzberg, Germany and was a member of the Diagnostics executive committee. He has held a number of key global executive positions at Roche during the past 22 years and has a wealth of experience in the Life Science industry.
Robert Yates to become president of Merck Millipore
He joins the firm from Roche
